Impact of surgical approach and survival prediction of malignant phyllode tumor by machine learning

Gongyin Zhang1, Foyan Xu2, Lixian Wan3

  • 1Department of Breast Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.

Updates in Surgery
|April 7, 2025
PubMed

Insights

Surgical approach, including mastectomy or breast-conserving surgery (BCS), does not significantly impact long-term survival for malignant phyllode tumor of the breast (MPTB). Machine learning models, particularly CatBoost, can predict survival outcomes for MPTB patients.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Data Science in Medicine

Background:

  • Malignant Phyllode Tumors of the Breast (MPTB) are rare and require careful treatment planning.
  • The impact of different surgical approaches on MPTB patient outcomes is not well-established.
  • Developing accurate prognostic models is crucial for personalized patient management.

Purpose of the Study:

  • To evaluate the effect of surgical approach (mastectomy vs. breast-conserving surgery) on survival in MPTB patients.
  • To develop and validate machine learning-based prognostic prediction models for MPTB.
  • To compare the efficacy of different machine learning algorithms in predicting MPTB survival.

Main Methods:

  • Retrospective analysis of MPTB patients (aged 18-80) from the SEER database (2000-2020).
  • Propensity-score matching (PSM) to reduce covariate imbalance.
  • Cox proportional hazard regression and Kaplan-Meier analysis for survival assessment.
  • Ten machine learning models were trained to predict 5-year breast cancer-specific survival (BCSS) and overall survival (OS).

Main Results:

  • Multivariate Cox analysis indicated no significant difference in long-term survival outcomes between mastectomy and breast-conserving surgery (BCS) for MPTB patients (p > 0.05).
  • This finding held true even for patients with poor pathologic types.
  • The CatBoost model demonstrated superior predictive performance, achieving an AUC of 0.8488 for 5-year BCSS and 0.8512 for 5-year OS.

Conclusions:

  • Surgical approach (mastectomy vs. BCS) does not significantly affect long-term survival in MPTB patients.
  • BCS is a feasible and preferred option when adequate surgical margins can be achieved.
  • The CatBoost model shows promise as a reliable tool for guiding systemic treatment decisions in MPTB management.